newsfilter
← Latest News
GlobeNewswire·

Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results

At June 30, 2021 had approximately $100 million in unrestricted cash and cash equivalents, funds held in trust and short-term investments Development of FT-104, a novel psychedelic molecule with pending patents, continues to progress with GMP productio